Clinical DataDISC-0974's mechanism of action and impressive clinical data generated to date show deep and sustained reductions in hepcidin levels, translating to compelling response rates.
Expert EndorsementThe webcast event featured commentary from two renowned hematologist-oncologists, indicating strong expert endorsement for DISC-0974 in MF anemia.
Market OpportunityThe attractive market opportunity for therapeutics in MF is highlighted by JAK inhibitors generating significant sales, despite having little to no effect on treating patients with anemia.